Cerebral perivascular spaces as predictors of dementia risk and accelerated brain atrophy
Barisano, G.; Iv, M.; Choupan, J.; Hayden Gephart, M.
Show abstract
Cerebral small vessel disease, an important risk factor for dementia, lacks robust, in vivo measurement methods. Perivascular spaces (PVS) on brain MRI are surrogates for small parenchymal blood vessels and their perivascular compartment, and may relate to brain health. We developed a novel, robust algorithm to automatically assess PVS count and size on MRI, and investigated their relationship with dementia risk and brain atrophy. We analyzed 46,478 clinical measurements of cognitive functioning and 20,845 brain MRI scans from 10,004 participants (71.1{+/-}9.7 years-old, 56.6% women). Fewer PVS and larger PVS diameter at baseline were associated with higher dementia risk and accelerated brain atrophy. Longitudinal trajectories of PVS markers were significantly different in non-demented individuals who converted to dementia compared with non-converters. In simulated placebo-controlled trials for treatments targeting cognitive decline, screening out participants less likely to develop dementia based on our PVS markers enhanced the power of the trial. These novel radiographic cerebrovascular markers may improve risk-stratification of individuals, potentially reducing cost and increasing throughput of clinical trials to combat dementia.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease 98%
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 97%
- Educational attainment, structural brain reserve, and Alzheimer’s disease: a Mendelian randomization analysis 97%
Similar papers in this journal
- Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease 97%
- Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease 97%
- Head-to-head comparison between plasma p-tau217 and Flortaucipir-PET in amyloid-positive patients with cognitive impairment 96%
Similar papers in this journal
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 97%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 97%
- AI-driven fusion of neurological work-up for assessment of biological Alzheimer’s disease 97%
Similar papers in this journal
- Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study 92%
- Susceptibility to postmortem (co)-pathologies in antemortem atrophy-based subtypes of Alzheimer’s disease 92%
- Lesions in putative language and attention regions are linked to more severe strokes in patients with higher white matter hyperintensity burden 92%